Edesa Biotech Ratio court
Quel est le Ratio court de Edesa Biotech?
Le Ratio court de Edesa Biotech, Inc. est 5.73
Quelle est la définition de Ratio court?
Le ratio court des actions vendues est le nombre d'actions vendues à découvert divisé par le volume quotidien moyen.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Ratio court des entreprises dans Health Care secteur sur NASDAQ par rapport à Edesa Biotech
Que fait Edesa Biotech?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Entreprises avec ratio court similaire à Edesa Biotech
- Deep-South Resources a Ratio court de 5.70
- Sensient Technologies a Ratio court de 5.71
- Skyline a Ratio court de 5.72
- Franchise International a Ratio court de 5.72
- Stantec Inc a Ratio court de 5.72
- Champion Homes a Ratio court de 5.72
- Edesa Biotech a Ratio court de 5.73
- Goosehead Insurance Inc a Ratio court de 5.74
- Western Copper & Gold Corp a Ratio court de 5.74
- Northeast Bank a Ratio court de 5.75
- Chewy Inc a Ratio court de 5.75
- Ziprecruiter a Ratio court de 5.75
- Hormel Foods a Ratio court de 5.75